CalciMedica Inc.

2.07
-0.13 (-5.91%)
At close: Mar 04, 2025, 1:53 PM

CalciMedica Income Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Revenue n/a n/a n/a n/a n/a n/a
Cost of Revenue 58K 52K 519K 395K 303K 175K
Gross Profit -58K -52K -519K -395K -303K -175K
Operating Income -21.88M -36.18M -35.95M -29.83M -37.5M -28.57M
Interest Income n/a 575K 126K 143K 393K 192K
Pretax Income -34.36M -35.6M -35.82M -27.53M -37.04M -28.38M
Net Income -34.36M -35.6M -35.82M -27.53M -37.04M -28.38M
Selling & General & Admin 9.46M 19.1M 17.04M 8.87M 6.92M 5.6M
Research & Development 12.36M 14.11M 18.9M 20.96M 30.58M 22.97M
Other Expenses n/a 2.96M n/a 2.16M 72K n/a
Operating Expenses 21.82M 33.22M 35.95M 29.83M 37.5M 28.57M
Interest Expense n/a n/a 126K 143K n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a n/a
Cost & Expenses 21.88M 33.22M 35.95M 29.83M 37.5M 28.57M
Income Tax -109.89K 2.39M -2M -538K -393K 13.86K
Shares Outstanding (Basic) 4.49M 1.53M 1.51M 472.75K 1.03M 857.28K
Shares Outstanding (Diluted) 4.49M 1.53M 1.51M 472.75K 1.03M 857.28K
EPS (Basic) -7.65 -23.2 -23.66 -58.24 -35.85 -33.1
EPS (Diluted) -7.65 -23.2 -23.66 -58.24 -35.85 -33.1
EBITDA -34.19M -7.64M -35.3M -27.14M -36.73M -28.2M
Depreciation & Amortization 58K 52K 519K 395K 303K 175K